83 related articles for article (PubMed ID: 3522995)
1. Heterophil Forssman glycoprotein and adenovirus 12: transformed rat cell lines.
Mori T; Mori E; Shigyo Y; Sudo T; Kano K
J Natl Cancer Inst; 1986 Jul; 77(1):115-20. PubMed ID: 3522995
[TBL] [Abstract][Full Text] [Related]
2. Expression of heterophil Forssman antigen on cultured malignant cell lines.
Mori T; Sudo T; Kano K
J Natl Cancer Inst; 1983 May; 70(5):811-8. PubMed ID: 6341675
[TBL] [Abstract][Full Text] [Related]
3. Expression of heterophil Forssman antigen as glycoprotein on transformed rat cell lines: shedding of the antigen from the cells.
Mori T; Mori E; Sudo T; Kano K
J Natl Cancer Inst; 1984 Nov; 73(5):1179-86. PubMed ID: 6436565
[TBL] [Abstract][Full Text] [Related]
4. Forssman antigen on yolk sac derived rat tumor cells.
Shigyo Y; Mori T; Kano K
Immunol Invest; 1986 Mar; 15(1):25-33. PubMed ID: 3519448
[TBL] [Abstract][Full Text] [Related]
5. Surface antigens of BK virus-induced tumor cells.
Karjalainen HE
Med Biol; 1981 Feb; 59(1):35-40. PubMed ID: 6267387
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity of simian virus 40-transformed rat hepatocytes.
Isom HC; Tevethia MJ; Kreider JW
Cancer Res; 1981 Jun; 41(6):2126-34. PubMed ID: 6263461
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro production and detection of monoclonal antibodies to surface components on metastatic variants of murine tumor cells.
Miner KM; Reading CL; Nicolson GL
Invasion Metastasis; 1981; 1(3):158-74. PubMed ID: 6897920
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies detecting different epitopes on the Forssman glycolipid hapten.
Sonnenberg A; van Balen P; Hengeveld T; Kolvenbag GJ; Van Hoeven RP; Hilgers J
J Immunol; 1986 Aug; 137(4):1264-9. PubMed ID: 2426359
[TBL] [Abstract][Full Text] [Related]
9. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
[TBL] [Abstract][Full Text] [Related]
11. Expression of varying portions of the adenovirus 12 early region 1 in transformed cells affects tumorigenicity and interaction with extracellular matrix components.
Bober FJ; Birk DE; Raska K
Lab Invest; 1987 Jan; 56(1):37-43. PubMed ID: 3795870
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
13. Apical and basal Forssman antigen in MDCK II cells: a morphological and quantitative study.
Butor C; Stelzer EH; Sonnenberg A; Davoust J
Eur J Cell Biol; 1991 Dec; 56(2):269-85. PubMed ID: 1802714
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of Forssman and Paul-Bunnell antigens on lymph node cells of MRL/Mp-lpr/lpr mice.
Katagiri T; Mori T; Nakano T; Ueno K; Kano K
J Immunol; 1984 Dec; 133(6):3143-8. PubMed ID: 6333455
[TBL] [Abstract][Full Text] [Related]
15. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
Harper JR; Bumol TF; Reisfeld RA
J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
[TBL] [Abstract][Full Text] [Related]
17. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
18. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
19. Expression of heterophile, Paul-Bunnell and Hanganutziu-Deicher antigens on human melanoma cell lines.
Nakarai H; Saida T; Shibata Y; Irie RF; Kano K
Int Arch Allergy Appl Immunol; 1987; 83(2):160-6. PubMed ID: 3294601
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody 45-2D9 recognizes a cell surface glycoprotein on a human c-Ha-ras transformed cell line (45-342) and a shared epitope on human tumors.
Roth JA; Ames RS; Restrepo C; Scuderi P
J Immunol; 1986 Oct; 137(7):2385-9. PubMed ID: 3531330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
